SPHK1 and cancer: The anti-cancer activity of FTY720 could be ascribed to the induction of protein phosphatase 2A (PP2A) activity and inhibition or degradation of sphingosine kinase 1, which is not dependent on FTY720 phosphorylation [53,54].